
How does Ozempic work? Understanding GLP-1s for diabetes, weight loss, and beyond

Zinc: What it does for the body, and the best food sources

Respiratory health harms often follow flooding: Taking these steps can help

Tips to leverage neuroplasticity to maintain cognitive fitness as you age

Can white noise really help you sleep better?

Celiac disease: Exploring four myths

What is prostatitis and how is it treated?

What is Cushing syndrome?

Exercises to relieve joint pain

Think your child has ADHD? What your pediatrician can do

Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt

Charlie Schmidt
The sequence of hormonal therapy and radiation affects outcomes in men treated for prostate cancer
Charlie Schmidt
New online model identifies which men can have fewer biopsies on active surveillance
Charlie Schmidt
Hormonal treatments for prostate cancer may prevent or limit COVID-19 symptoms
Charlie Schmidt
Hormonal treatments for prostate cancer are often given late
Charlie Schmidt
A new hormonal therapy for prostate cancer is under expedited FDA review
Charlie Schmidt
New drugs approved for advanced BRCA-positive prostate cancer
Charlie Schmidt
Combining different biopsies limits uncertainty in prostate cancer diagnosis
Charlie Schmidt
New radiation therapies keep advanced prostate cancer in check
Charlie Schmidt
New study compares long-term side effects from different prostate cancer treatments
Charlie Schmidt
African American and white men who receive comparable treatments for prostate cancer have similar survival
Charlie Schmidt
Researchers urge prostate cancer screening for men with BRCA gene defects
Charlie Schmidt
Most men can hold off on radiation after prostate cancer surgery
Charlie Schmidt
Darolutamide approved for nonmetastatic castration-resistant prostate cancer
Men's Health
Common hormonal treatments linked to abnormal heart rhythms and sudden death in men being treated for prostate cancer
Charlie Schmidt
Popular drugs used for treating enlarged prostates associated with high-grade prostate cancer
Charlie Schmidt
From Brexit to TRexit: Transperineal biopsies pose a challenge to the traditional transrectal biopsy method
Charlie Schmidt
Can a man with abnormal PSA and a negative diagnostic MRI avoid a prostate biopsy? It’s debatable
Charlie Schmidt
Highly accurate test reveals recurring prostate cancer

Men's Health
African American men respond better to treatments for advanced prostate cancer in clinical trials
Charlie Schmidt
Diet and exercise limit heart disease risk in men undergoing hormonal treatments for advanced prostate cancer

Charlie Schmidt
Hormonal therapy for aggressive prostate cancer: How long is enough?
Charlie Schmidt
Long-term statin use protects against prostate cancer death

Charlie Schmidt
Smoking tied to more aggressive prostate cancer
Charlie Schmidt
Investigators unveil metastatic prostate cancer’s genomic landscape

How does Ozempic work? Understanding GLP-1s for diabetes, weight loss, and beyond

Zinc: What it does for the body, and the best food sources

Respiratory health harms often follow flooding: Taking these steps can help

Tips to leverage neuroplasticity to maintain cognitive fitness as you age

Can white noise really help you sleep better?

Celiac disease: Exploring four myths

What is prostatitis and how is it treated?

What is Cushing syndrome?

Exercises to relieve joint pain

Think your child has ADHD? What your pediatrician can do